ReviewDiabetology & metabolic syndrome2025

Impact of GLP-1 receptor agonist-based therapies on cardiovascular and renal outcomes in diabetic and non-diabetic patients with CKD.

Aliona Siniukovich et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.